ELMSFORD, N.Y., Feb. 6, 2014 /PRNewswire/
-- BioScrip®, Inc. (NASDAQ: BIOS) ("BioScrip")
today announced that it has priced its private placement of
$200.0 million aggregate principal
amount of 8.875% senior unsecured notes due 2021. The offering is
expected to close on February 11,
2014, subject to the satisfaction of customary closing
conditions.
BioScrip intends to use the net proceeds of the offering to pay
a portion of the amounts outstanding on its $75 million senior
secured first-lien revolving credit facility, its $150 million senior secured first-lien delayed
draw term loan B and its $250 million
senior secured first-lien term loan B.
The notes and related guarantees are being offered in a private
placement, solely to qualified institutional buyers in reliance on
Rule 144A under the Securities Act of 1933, as amended (the
"Securities Act"), or outside the United
States to persons other than "U.S. persons" in compliance
with Regulation S under the Securities Act. The notes and related
guarantees have not been registered under the Securities Act or the
securities laws of any other jurisdiction and may not be offered or
sold in the United States absent
registration or an applicable exemption from the registration
requirements.
This notice does not constitute an offer to sell the notes, nor
a solicitation for an offer to purchase the notes, in any
jurisdiction in which such offer or solicitation would be unlawful.
Any offer of the notes will be made only by means of a private
offering memorandum. This press release is being issued pursuant to
and in accordance with Rule 135c under the Securities Act.
About BioScrip, Inc.
BioScrip, Inc. provides
comprehensive infusion and home care solutions. By partnering with
patients, physicians, healthcare payors, government agencies and
pharmaceutical manufacturers, we are able to provide access to
infusible medications and management solutions. Our goal is to
optimize outcomes for chronic and other complex healthcare
conditions and enhance the quality of patient life. BioScrip brings
clinical competence in providing high-touch, comprehensive infusion
and nursing services to patients in the most convenient ways
possible. Through our customer services and treatments we aim to
ensure the best possible therapy outcome.
Contact:
Hai Tran
BioScrip, Inc.
952-979-3768
SOURCE BioScrip, Inc.